SE7808414L - Solidifierad farmaceutisk komposition innefattande cellveggskelett - Google Patents

Solidifierad farmaceutisk komposition innefattande cellveggskelett

Info

Publication number
SE7808414L
SE7808414L SE7808414A SE7808414A SE7808414L SE 7808414 L SE7808414 L SE 7808414L SE 7808414 A SE7808414 A SE 7808414A SE 7808414 A SE7808414 A SE 7808414A SE 7808414 L SE7808414 L SE 7808414L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
cell wall
composition including
including cell
wall skeleton
Prior art date
Application number
SE7808414A
Other languages
English (en)
Other versions
SE447629B (sv
Inventor
Sok
Original Assignee
Yamamura Yuichi
Azuma Ichiro
Ennyu Katsusuke
Aoki Osamu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamamura Yuichi, Azuma Ichiro, Ennyu Katsusuke, Aoki Osamu filed Critical Yamamura Yuichi
Publication of SE7808414L publication Critical patent/SE7808414L/sv
Publication of SE447629B publication Critical patent/SE447629B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7808414A 1977-08-09 1978-08-04 Till fast form overford farmaceutisk komposition innehallande cellveggskelett av nocardia rubra SE447629B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same

Publications (2)

Publication Number Publication Date
SE7808414L true SE7808414L (sv) 1979-02-10
SE447629B SE447629B (sv) 1986-12-01

Family

ID=14149407

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7808414A SE447629B (sv) 1977-08-09 1978-08-04 Till fast form overford farmaceutisk komposition innehallande cellveggskelett av nocardia rubra

Country Status (15)

Country Link
US (1) US4543253A (sv)
JP (1) JPS5428813A (sv)
AU (1) AU526788B2 (sv)
BE (1) BE869610A (sv)
CA (1) CA1118348A (sv)
CH (1) CH643459A5 (sv)
DE (1) DE2834893A1 (sv)
DK (1) DK153443C (sv)
FI (1) FI65370C (sv)
FR (1) FR2399844A1 (sv)
GB (1) GB2002229B (sv)
HU (1) HU179726B (sv)
IT (1) IT1098381B (sv)
NL (1) NL7808337A (sv)
SE (1) SE447629B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DD273198A5 (de) * 1986-06-09 1989-11-08 �������@�������k���Kk�� Verfahren zur herstellung eines modifikationsmittels
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
EP1097715A4 (en) * 1998-07-16 2004-12-29 Hayashi Akira PREPARATIONS FOR ANTICANCER IMMUNOTHERAPY COMPRISING A BACTERIAL SOMATIC COMPONENT AS AN ACTIVE INGREDIENT
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
US20080032384A1 (en) * 2004-04-22 2008-02-07 Takehiko Nomura Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
CN115300490B (zh) * 2021-05-07 2024-04-16 安徽远望乐桓药业有限公司 包含角鲨烯和甘露醇的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185623A (en) * 1960-05-31 1965-05-25 Smith Fred Preservation of animal semen
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
FR2268531B1 (sv) * 1974-04-25 1978-07-21 Anvar
FR2275224A1 (fr) * 1974-06-20 1976-01-16 Anvar Fractions mycobacteriennes utilisables comme agent anti-infectieux, et procede pour leur preparation
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens

Also Published As

Publication number Publication date
FR2399844A1 (fr) 1979-03-09
FR2399844B1 (sv) 1982-08-20
IT7826609A0 (it) 1978-08-08
DE2834893C2 (sv) 1987-08-27
US4543253A (en) 1985-09-24
JPS631291B2 (sv) 1988-01-12
FI65370C (fi) 1984-05-10
HU179726B (en) 1982-11-29
GB2002229A (en) 1979-02-21
JPS5428813A (en) 1979-03-03
AU526788B2 (en) 1983-02-03
CH643459A5 (de) 1984-06-15
GB2002229B (en) 1982-05-26
DE2834893A1 (de) 1979-02-22
DK153443B (da) 1988-07-18
BE869610A (fr) 1979-02-08
FI65370B (fi) 1984-01-31
SE447629B (sv) 1986-12-01
IT1098381B (it) 1985-09-07
DK153443C (da) 1988-12-05
DK352578A (da) 1979-02-10
CA1118348A (en) 1982-02-16
NL7808337A (nl) 1979-02-13
FI782442A (fi) 1979-02-10
AU3879178A (en) 1980-02-14

Similar Documents

Publication Publication Date Title
SE7810591L (sv) Farmaceutiska kompositioner
SE7806446L (sv) Farmaceutisk komposition med forlengd upplosningstid
DK137878A (da) Tabletopbygning
FI783917A (fi) Aminderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner
JPS53113007A (en) Pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
BE872319A (fr) Composition pharmaceutique
MX148578A (es) Estructura mejorada combinada de electrolito-electrodo
FI782481A (fi) Foerfarande foer framstaellning av nya organiska foereningar
JPS5449333A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
IT1095377B (it) Composizione farmaceutica
SE7808414L (sv) Solidifierad farmaceutisk komposition innefattande cellveggskelett
GB2021409B (en) Pharmaceutical composition
FI780463A (fi) Tablettkross
IT7849938A0 (it) Composizioni farmaceutiche
SE7806441L (sv) Lekemedelskomposition
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
JPS5486607A (en) Solid pharmaceutical composition
SE7806559L (sv) Anordning vid behallare
JPS5394038A (en) Pharmaceutical composition
JPS53101520A (en) Pharmaceutical composition
DK144799C (da) Rensevaeske
SE7812345L (sv) Sjelvsleckande polystyrenkomposition
FI781507A (fi) Farmaceutiska kompositioner

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7808414-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7808414-2

Format of ref document f/p: F